In addition to weight loss and metabolic control, an impressive number of randomized controlled trials and meta-analyses have demonstrated a cardiovascular protective effect of GLP-1 RAs in populations with diabetes, hence, lowering risks of myocardial infarction, stroke, and cardiovascular mortality [9-10]. The gene discussed is GCG; the disease is stroke disorder.